Matthieu Legrand
Critical Care Medicine San Francisco, CA Medical Doctor
NPI 1033752365 CMS profile 7221491
500 Parnassus Ave, San Francisco, CA 94143
General payments
$16,035
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$74,594
Through program year 2025, Matthieu Legrand of San Francisco, CA is reported in the CMS Open Payments database as having received $16,035 across 22 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $74,594 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 95th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $6,155 | 16 | |
| 2024 | General | $8,443 | 4 | |
| 2023 | General | $1,437 | 2 |
Beside peers
- Matthieu Legrand
- Critical Care Medicine median
- Middle half of Critical Care Medicine
- National median
In program year 2025, general payments to Matthieu Legrand were reported at $6,155. Among 445 Critical Care Medicine profiles paid that year, the median was $97 and the middle half received between $33 and $255.
Show as a table
| Year | Matthieu Legrand | Critical Care Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $103 | $29–$256 | $163 |
| 2020 | $0 | $60 | $22–$164 | $114 |
| 2021 | $0 | $115 | $30–$249 | $132 |
| 2022 | $0 | $97 | $27–$196 | $149 |
| 2023 | $1,437 | $104 | $31–$245 | $160 |
| 2024 | $8,443 | $93 | $28–$268 | $164 |
| 2025 | $6,155 | $97 | $33–$255 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 27 billing codesPaid by Medicare
$20,227
Medicare patients
72
Services billed
142
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Chronic kidney disease | 50% | |
| Ischemic heart disease | 49% | |
| Diabetes | 44% | |
| Arthritis | 44% | |
| Heart failure | 43% | |
| Atrial fibrillation | 40% | |
| Depression | 38% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
22 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Critical Care Medicine in California
Vanessa Moll
Critical Care Medicine · Stanford, CA
Romain Pirracchio
Critical Care Medicine · San Francisco, CA
Roger Mecca
Critical Care Medicine · Stanford, CA
Anushirvan Minokadeh
Critical Care Medicine · San Diego, CA
Juliana Barr
Critical Care Medicine · Palo Alto, CA
Xiaodong Yang
Critical Care Medicine · West Hollywood, CA
Related records
Critical Care Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Critical Care Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.